Alphapharm slams Sanofi amendment delay in injunction battle

Intellectual Property 2018-11-02 10:09 pm By Miklos Bolza | Sydney

Generic drug maker Alphapharm says rival Sanofi-Aventis waited to amend its injector pen patent until the heated IP battle between the two firms had commenced, despite knowing about the amendments for three years.